These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29945166)

  • 21. The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.
    Manohar P; Nachimuthu R; Lopes BS
    BMC Microbiol; 2018 Aug; 18(1):97. PubMed ID: 30170558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of zinc in enteropathogenic Escherichia coli infection.
    Crane JK; Naeher TM; Shulgina I; Zhu C; Boedeker EC
    Infect Immun; 2007 Dec; 75(12):5974-84. PubMed ID: 17875638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution, functional expression, and genetic organization of Cif, a phage-encoded type III-secreted effector from enteropathogenic and enterohemorrhagic Escherichia coli.
    Loukiadis E; Nobe R; Herold S; Tramuta C; Ogura Y; Ooka T; Morabito S; Kérourédan M; Brugère H; Schmidt H; Hayashi T; Oswald E
    J Bacteriol; 2008 Jan; 190(1):275-85. PubMed ID: 17873042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Higher atypical enteropathogenic Escherichia coli (a-EPEC) bacterial loads in children with diarrhea are associated with PCR detection of the EHEC factor for adherence 1/lymphocyte inhibitory factor A (efa1/lifa) gene.
    Slinger R; Lau K; Slinger M; Moldovan I; Chan F
    Ann Clin Microbiol Antimicrob; 2017 Mar; 16(1):16. PubMed ID: 28330478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence and molecular characterization of enteropathogenic Escherichia coli serotypes isolated from children with diarrhoea in Najaf, Iraq.
    Al Hilali SA; Almohana AM
    Indian J Med Microbiol; 2011; 29(4):383-8. PubMed ID: 22120799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of BI-EHEC and BI-EPEC bacteriophages to control enterohemorrhagic and enteropathogenic escherichia coli on various food surfaces.
    L A LA; Waturangi DE
    BMC Res Notes; 2023 Jun; 16(1):102. PubMed ID: 37312167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The comparison of lytic activity of isolated phage and commercial Intesti bacteriophage on ESBL producer E. coli and determination of Ec_P6 phage efficacy with in vivo Galleria mellonella larvae model.
    Erol HB; Kaskatepe B; Ozturk S; Safi Oz Z
    Microb Pathog; 2022 Jun; 167():105563. PubMed ID: 35513294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacteriophage DW-EC with the capability to destruct and inhibit biofilm formed by several pathogenic bacteria.
    Wiguna OD; Waturangi DE; Yogiara
    Sci Rep; 2022 Nov; 12(1):18539. PubMed ID: 36329103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation and Characterization of Bacteriophages That Infect
    Mizuno CM; Luong T; Cederstrom R; Krupovic M; Debarbieux L; Roach DR
    Viruses; 2020 Jul; 12(7):. PubMed ID: 32650458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility of Escherichia coli isolated from uteri of postpartum dairy cows to antibiotic and environmental bacteriophages. Part I: Isolation and lytic activity estimation of bacteriophages.
    Bicalho RC; Santos TM; Gilbert RO; Caixeta LS; Teixeira LM; Bicalho ML; Machado VS
    J Dairy Sci; 2010 Jan; 93(1):93-104. PubMed ID: 20059908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lysogenic conversion of atypical enteropathogenic Escherichia coli (aEPEC) from human, murine, and bovine origin with bacteriophage Φ3538 Δstx
    Eichhorn I; Heidemanns K; Ulrich RG; Schmidt H; Semmler T; Fruth A; Bethe A; Goulding D; Pickard D; Karch H; Wieler LH
    Int J Med Microbiol; 2018 Oct; 308(7):890-898. PubMed ID: 29937391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic characterization of Shiga toxin-producing Escherichia coli (STEC) and atypical enteropathogenic Escherichia coli (EPEC) isolates from goat's milk and goat farm environment.
    Álvarez-Suárez ME; Otero A; García-López ML; Dahbi G; Blanco M; Mora A; Blanco J; Santos JA
    Int J Food Microbiol; 2016 Nov; 236():148-54. PubMed ID: 27497630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phage Therapy of Pneumonia Is Not Associated with an Overstimulation of the Inflammatory Response Compared to Antibiotic Treatment in Mice.
    Dufour N; Delattre R; Chevallereau A; Ricard JD; Debarbieux L
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic characterization of antibiotic resistance in enteropathogenic Escherichia coli carrying extended-spectrum beta-lactamases recovered from diarrhoeic rabbits.
    Poeta P; Radhouani H; Gonçalves A; Figueiredo N; Carvalho C; Rodrigues J; Igrejas G
    Zoonoses Public Health; 2010 May; 57(3):162-70. PubMed ID: 19309480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral infection with enteropathogenic Escherichia coli triggers immune response and intestinal histological alterations in mice selected for their minimal acute inflammatory responses.
    Vulcano AB; Tino-De-Franco M; Amaral JA; Ribeiro OG; Cabrera WH; Bordenalli MA; Carbonare CB; Álvares EP; Carbonare SB
    Microbiol Immunol; 2014 Jun; 58(6):352-9. PubMed ID: 24750489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of enteropathogenic Escherichia coli (EPEC) diagnosis by serology and by polymerase chain reaction (PCR)].
    Lluque A; Mercado E; Riveros M; Alvarado L; Carlos E; Colichón A; Salazar E; Ochoa T
    Rev Gastroenterol Peru; 2010; 30(2):121-5. PubMed ID: 20644603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of two new intimin types in atypical enteropathogenic Escherichia coli.
    Blanco M; Blanco JE; Dahbi G; Alonso MP; Mora A; Coira MA; Madrid C; Juárez A; Bernárdez MI; González EA; Blanco J
    Int Microbiol; 2006 Jun; 9(2):103-10. PubMed ID: 16835840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic effectiveness of bacteriophages in the rescue of mice with extended spectrum beta-lactamase-producing Escherichia coli bacteremia.
    Wang J; Hu B; Xu M; Yan Q; Liu S; Zhu X; Sun Z; Tao D; Ding L; Reed E; Gong J; Li QQ; Hu J
    Int J Mol Med; 2006 Feb; 17(2):347-55. PubMed ID: 16391836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli.
    Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A
    Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial Resistance Profiles of Enterohemorrhagic and Enteropathogenic Escherichia coli of Serotypes O157:H7, O26:H11, O103:H2, O111:H8, O145:H28 Compared to Escherichia coli Isolated from the Same Adult Cattle.
    Um MM; Brugère H; Kérourédan M; Oswald E; Bibbal D
    Microb Drug Resist; 2018; 24(6):852-859. PubMed ID: 29723122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.